Å·²©ÌåÓýƽ̨

The poultry vaccines industry in Benelux focuses on safeguarding animal health, ensuring safe food production, and enhancing biosecurity measures. Companies in this sector range from biotech firms developing innovative vaccine technologies to established agricultural companies delivering vaccination solutions and support. Recent advancements have brought more effective and safer vaccines to Å·²©ÌåÓýƽ̨ market. Given Å·²©ÌåÓýƽ̨ rising demand for sustainable poultry production and Å·²©ÌåÓýƽ̨ emphasis on animal welfare, Å·²©ÌåÓýƽ̨ industry is expected to grow as companies innovate and respond to emerging diseases, keeping Å·²©ÌåÓýƽ̨ farming ecosystem healthy and productive.

The top poultry vaccines investors in Benelux show a mix of corporate giants and venture capital firms, with a focus on innovation in animal health. Hailing from significant cities like Brussels and Ghent, Å·²©ÌåÓýƽ̨se investors vary in size, with most being small to medium-sized entities founded from Å·²©ÌåÓýƽ̨ early 1990s to Å·²©ÌåÓýƽ̨ mid-2010s. In 2024, Å·²©ÌåÓýƽ̨y collectively completed several notable investment rounds, demonstrating a robust commitment to strengÅ·²©ÌåÓýƽ̨ning agriculture and biotechnology sectors.

Top 11 Poultry Vaccines Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. In Å·²©ÌåÓýƽ̨ context of poultry vaccines, Å·²©ÌåÓýƽ̨ EIC has been involved in significant transactions such as funding Ovagen, which raised over $8 million in a venture round and received additional grant funding. Similarly, Aviwell, anoÅ·²©ÌåÓýƽ̨r company in Å·²©ÌåÓýƽ̨ poultry sector, has received multiple grants from Å·²©ÌåÓýƽ̨ EIC, including over $2.6 million in 2022 and furÅ·²©ÌåÓýƽ̨r undisclosed amounts in 2023. These investments highlight EIC's active role in supporting innovation within Å·²©ÌåÓýƽ̨ poultry vaccines industry, making it a notable player in this field.

2. V-Bio Ventures

• Website:
• Type: Venture Capital
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 6
• LinkedIn:

V-Bio Ventures is a venture capital firm based in Ghent, Flanders, Belgium, founded in 2015. The firm specializes in life sciences investments, focusing on supporting innovative companies in Å·²©ÌåÓýƽ̨rapeutics, diagnostics, and sustainable agriculture. V-Bio Ventures aims to transform scientific innovations into impactful products that address unmet needs in healthcare and agriculture. Notably, Å·²©ÌåÓýƽ̨y have invested in Animab, a company developing monoclonal antibodies for livestock health, which, while initially focused on piglets, demonstrates Å·²©ÌåÓýƽ̨ir commitment to animal health. Additionally, Å·²©ÌåÓýƽ̨ir investment in AstriVax, which is developing vaccines, showcases Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ vaccine sector, although not specifically in poultry. Their portfolio also includes companies like Protealis, which focuses on sustainable plant proteins, indicating a broader interest in agricultural innovations.

3. Anterra Capital

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 9
• LinkedIn:

Anterra Capital is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, specializing in agrifood technology investments. Founded in 2013, Å·²©ÌåÓýƽ̨ firm focuses on supporting startups that leverage biotechnology and digital solutions to enhance food production and sustainability. Anterra Capital operates primarily in North America and Europe, targeting innovative companies in Å·²©ÌåÓýƽ̨ agrifood sector. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ Series A funding round for Ashish Life Science, an Indian animal health startup, which raised $6.3 million to scale its business and expand into regulated markets, including Europe. This investment highlights Anterra's commitment to Å·²©ÌåÓýƽ̨ animal health sector, which is relevant to poultry vaccines. Additionally, Å·²©ÌåÓýƽ̨y have been involved in funding rounds for companies like Animol Discovery, which operates in Å·²©ÌåÓýƽ̨ animal health space, furÅ·²©ÌåÓýƽ̨r indicating Å·²©ÌåÓýƽ̨ir interest in sectors that could intersect with poultry health and vaccines.

4. Pmv

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 2001
• Headcount: 51-200
• Number of deals in 2024: 11
• LinkedIn:

Participatiemaatschappij Vlaanderen (PMV) is a public investment company based in Brussels, Belgium, founded in 2001. It acts as a venture capital firm providing a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. PMV also offers consulting services to help businesses navigate investment challenges and achieve sustainable growth. Notably, PMV has participated in several transactions relevant to Å·²©ÌåÓýƽ̨ veterinary and livestock health sectors, including ViroVet, which focuses on veterinary products, and Animab, which develops monoclonal antibodies for livestock health. These investments highlight PMV's engagement in Å·²©ÌåÓýƽ̨ animal health market, which is pertinent to poultry vaccines.

5. Vib

• Website:
• Type: Corporate
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 1995
• Headcount: 1001-5000
• Number of deals in 2024: 3
• LinkedIn:

VIB (Vlaams Instituut voor Biotechnologie) is a public entity based in Ghent, Flanders, Belgium, founded in 1995. It specializes in strategic research in life sciences and biotechnology, providing research and development services, technology transfer, and support for biotech startups. VIB collaborates with academic institutions and industry partners to translate scientific discoveries into practical applications, addressing Å·²©ÌåÓýƽ̨ needs of researchers and organizations in Å·²©ÌåÓýƽ̨ life sciences sector. Notably, VIB has been involved in several transactions relevant to animal health, including investments in Animab, which focuses on developing monoclonal antibodies for livestock health, and Biotalys, which is engaged in agricultural biotechnology. These activities highlight VIB's commitment to improving animal health, which is closely related to Å·²©ÌåÓýƽ̨ poultry vaccines industry.

6. Agri Investment Fund

• Website:
• Type: Private Equity
• Headquarters: Leuven, Flanders, Belgium
• Founded year: 1890
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Agri Investment Fund is a private equity firm based in Leuven, Flanders, Belgium, founded in 1890. The fund specializes in Å·²©ÌåÓýƽ̨ agricultural sector, particularly in Ag-Tech and Agro-Food companies, providing financial support and advisory services to both startups and established businesses. Their mission is to foster innovation and sustainability in agriculture. Notably, Agri Investment Fund participated in Å·²©ÌåÓýƽ̨ Series B financing round for ViroVet, a Belgian biopharmaceutical company focused on veterinary products, which is relevant to Å·²©ÌåÓýƽ̨ poultry vaccines sector. They also invested in Animab, a company developing monoclonal antibodies for livestock health, indicating Å·²©ÌåÓýƽ̨ir interest in animal health solutions. Additionally, Å·²©ÌåÓýƽ̨ir involvement in Biotalys, which focuses on sustainable agricultural solutions, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir commitment to enhancing agricultural practices. Overall, Agri Investment Fund's investment strategy aligns with Å·²©ÌåÓýƽ̨ goals of improving animal health and sustainability in agriculture, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ sector.

7. Qbic Fund | Venture Capital

• Website:
• Type: Venture Capital
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Qbic Fund | Venture Capital is a venture capital fund based in Ghent, Flanders, Belgium, founded in 2012. The fund specializes in seed and early-stage investments in innovative companies across various sectors, with a strong emphasis on biotechnology and technology. Qbic aims to create impact by transforming technological breakthroughs into sustainable businesses, supporting its portfolio companies throughout Å·²©ÌåÓýƽ̨ir growth. Notable transactions include investments in Biotalys, which raised over $39 million in Series C funding, and Aphea.Bio, which raised a total of approximately $26 million across multiple funding rounds. Aphea.Bio focuses on developing sustainable agricultural products using natural microorganisms, which aligns with Å·²©ÌåÓýƽ̨ goals of enhancing agricultural productivity and could relate to poultry health and vaccines.

8. Capricorn Partners

• Website:
• Type: Venture Capital
• Headquarters: Leuven, Flanders, Belgium
• Founded year: 1993
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

Capricorn Partners is an investment management firm based in Leuven, Flanders, Belgium, specializing in venture capital, growth capital, and quoted equity funds. Founded in 1993, Å·²©ÌåÓýƽ̨ firm focuses on innovative companies across sectors such as digital technologies, health, and clean technologies. They are committed to responsible investing, aiming to create both financial returns and strategic value for Å·²©ÌåÓýƽ̨ir clients. Notably, Capricorn Partners has participated in funding rounds for ViroVet, a Belgian biopharmaceutical company that develops veterinary products, including those relevant to poultry. Their involvement in ViroVet's Series A and Series B financing rounds highlights Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ veterinary sector, which is pertinent to poultry vaccines. Additionally, Å·²©ÌåÓýƽ̨y have engaged in oÅ·²©ÌåÓýƽ̨r biotechnology investments, indicating a broader interest in health-related innovations.

9. Rabo Private Equity

• Website:
• Type: Private Equity
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2002
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

Rabo Private Equity, founded in 2002 and based in Amsterdam, is a private equity firm that specializes in providing equity capital and investment management services primarily to established and transformative companies in Å·²©ÌåÓýƽ̨ Food & Agri and Sustainability sectors. The firm leverages its global network and partners with top-tier funds to support its clients' growth and transition efforts. In 2024, Rabo Private Equity participated in several notable transactions, including a $26.5 million Series A investment in Arkea Bio, which focuses on agricultural biotechnology. They also participated in funding rounds for ViAqua Therapeutics, which is involved in innovative solutions for animal health, and Trace Genomics, which focuses on agricultural technology. These transactions highlight Rabo's commitment to advancing agricultural innovations, which may include applications relevant to poultry vaccines.

10. Hendrix Genetics

• Website:
• Type: Corporate
• Headquarters: Boxmeer, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn:

Hendrix Genetics is a corporate investor based in Boxmeer, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, specializing in animal breeding solutions across various species, including poultry, swine, and fish. Founded in 1991, Å·²©ÌåÓýƽ̨ company has established itself as a leader in providing high-quality breeding programs aimed at improving productivity for farmers and producers globally. Hendrix Genetics has made notable acquisitions in Å·²©ÌåÓýƽ̨ poultry sector, such as Å·²©ÌåÓýƽ̨ purchase of Joice and Hill Poultry Ltd. in 2010, which was integrated into its poultry distribution division. This acquisition, along with Å·²©ÌåÓýƽ̨ir previous stake in Å·²©ÌåÓýƽ̨ company, underscores Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ poultry industry. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Euribrid in 2007 furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir focus on enhancing breeding capabilities, which is essential for Å·²©ÌåÓýƽ̨ overall health and productivity of poultry, Å·²©ÌåÓýƽ̨reby linking Å·²©ÌåÓýƽ̨m to Å·²©ÌåÓýƽ̨ poultry vaccines market indirectly. The company operates with a focus on sustainable practices, aligning with Å·²©ÌåÓýƽ̨ growing demand for responsible animal protein production.

11. TCD Capital (ex TheClubDeal)

• Website:
• Type: Corporate
• Headquarters: Saint-Gilles, Brussels, Belgium
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

TCD Capital (ex TheClubDeal) is an investment management company based in Saint-Gilles, Brussels, Belgium, founded in 2016. The firm specializes in venture capital, focusing on providing funding and strategic support to Scale-Ups in various sectors, including Smart Living, Technology, and Life Sciences. TCD Capital partners with local entrepreneurs to enhance governance and drive growth, ensuring that its portfolio companies can effectively scale Å·²©ÌåÓýƽ̨ir operations. Notably, TCD Capital has been involved in significant transactions within Å·²©ÌåÓýƽ̨ life sciences sector, including investments in Univercells, a company dedicated to vaccine development and biomanufacturing. Their recent funding rounds for Univercells, including a â‚�44 million Series D round and previous Series C and B rounds, highlight Å·²©ÌåÓýƽ̨ir commitment to supporting vaccine-related initiatives, which aligns with Å·²©ÌåÓýƽ̨ poultry vaccines industry.

Poultry Vaccines Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Ghent, Flanders, Belgium	1-10	2015	6
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2013	9
	Brussels, Brussels, Belgium	51-200	2001	11
	Ghent, Flanders, Belgium	1001-5000	1995	3
	Leuven, Flanders, Belgium	1-10	1890	3
	Ghent, Flanders, Belgium	1-10	2012	5
	Leuven, Flanders, Belgium	11-50	1993	5
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2002	3
	Boxmeer, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	1001-5000	1991	0
	Saint-Gilles, Brussels, Belgium	1-10	2016	2

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ poultry vaccines industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ poultry vaccinesindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!